Sign in
4

Changes in Ownership

Definium Therapeutics, Inc. Filed Acc 0001193125-26-126825

Chief Executive Officer sold 24,431 shares at $18.47 ($451,241)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Barrow Robert · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-03-25 Sale : show line 1 in the form 10b5-1 −24,431 $18.47 $451,241 752,454 D
Open-market sales · 24,431 sh · avg $18.47 · $451,241
Loading xslF345X06/ownership.xml…